| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2022-03-07 02:49:04 UTC |
|---|
| HMDB ID | HMDB0000583 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Docosanamide |
|---|
| Description | Docosanamide, also known as behenamide, belongs to the class of organic compounds known as fatty amides. These are carboxylic acid amide derivatives of fatty acids, that are formed from a fatty acid and an amine. Thus, docosanamide is considered to be a fatty amide. Based on a literature review a significant number of articles have been published on Docosanamide. |
|---|
| Structure | CCCCCCCCCCCCCCCCCCCCCC(N)=O InChI=1S/C22H45NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H2,23,24) |
|---|
| Synonyms | | Value | Source |
|---|
| Behenamide | HMDB | | Behenic acid amide | HMDB | | Behenic amide | HMDB | | Behenylamide | HMDB |
|
|---|
| Chemical Formula | C22H45NO |
|---|
| Average Molecular Weight | 339.5988 |
|---|
| Monoisotopic Molecular Weight | 339.350115067 |
|---|
| IUPAC Name | docosanamide |
|---|
| Traditional Name | behenamide |
|---|
| CAS Registry Number | 3061-75-4 |
|---|
| SMILES | CCCCCCCCCCCCCCCCCCCCCC(N)=O |
|---|
| InChI Identifier | InChI=1S/C22H45NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H2,23,24) |
|---|
| InChI Key | ORAWFNKFUWGRJG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as fatty amides. These are carboxylic acid amide derivatives of fatty acids, that are formed from a fatty acid and an amine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty amides |
|---|
| Direct Parent | Fatty amides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Fatty amide
- Primary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 11.4 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 29.0709 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.99 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 45.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3467.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 833.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 316.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 424.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 683.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1164.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1124.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 125.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2722.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 696.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2235.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 981.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 565.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 826.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 533.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Docosanamide,1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C | 2836.4 | Semi standard non polar | 33892256 | | Docosanamide,1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C | 2733.7 | Standard non polar | 33892256 | | Docosanamide,1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C | 2963.1 | Standard polar | 33892256 | | Docosanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2971.3 | Semi standard non polar | 33892256 | | Docosanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2887.3 | Standard non polar | 33892256 | | Docosanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2761.5 | Standard polar | 33892256 | | Docosanamide,1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C(C)(C)C | 3025.0 | Semi standard non polar | 33892256 | | Docosanamide,1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C(C)(C)C | 2938.4 | Standard non polar | 33892256 | | Docosanamide,1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N[Si](C)(C)C(C)(C)C | 3000.6 | Standard polar | 33892256 | | Docosanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3398.3 | Semi standard non polar | 33892256 | | Docosanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3207.6 | Standard non polar | 33892256 | | Docosanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2966.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Docosanamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9780000000-2e9365899b245c25c6a7 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Docosanamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Docosanamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 10V, Positive-QTOF | splash10-006x-0019000000-e08ec8abb87f590adbaf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 20V, Positive-QTOF | splash10-00di-3569000000-6795fc54dfaff10f0e22 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 40V, Positive-QTOF | splash10-052f-7960000000-20225e25812ed3ec5c05 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 10V, Negative-QTOF | splash10-000i-0009000000-c9cab6c3ce1e2dda926d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 20V, Negative-QTOF | splash10-000l-5029000000-58c604b1d86e4cf7315d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 40V, Negative-QTOF | splash10-0006-9000000000-2f8ebf6363213a9f2094 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 10V, Positive-QTOF | splash10-0006-2009000000-dc2a0b726e3adca1a049 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 20V, Positive-QTOF | splash10-0596-9037000000-05d45aa71b09eee5c3dd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 40V, Positive-QTOF | splash10-0a4l-9000000000-3a2028429d1b2fab33ef | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 10V, Negative-QTOF | splash10-000i-0009000000-441ed6bf73e3a5fc5b7f | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 20V, Negative-QTOF | splash10-0006-9004000000-da66ea2df9347ec28f8f | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosanamide 40V, Negative-QTOF | splash10-0006-9000000000-90726b17dc36e29c5299 | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|